These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23638231)

  • 21. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
    Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
    Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
    McCluggage WG; Young RH
    Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Struma salpingis associated with struma ovarii.
    Hoda SA; Huvos AG
    Am J Surg Pathol; 1993 Nov; 17(11):1187-9. PubMed ID: 8214265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.
    Gagne LJ; Colacchio T; Longnecker DS
    Int J Pancreatol; 2000 Aug; 28(1):9-13. PubMed ID: 11185714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary mucinous gland lesions of fallopian tube: a clinicopathological analysis of fourteen cases].
    Zhang LL; Xu Y; Ji ST; Ning Y; Gu WY
    Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):546-551. PubMed ID: 38825898
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
    Li XS; Sun J; He XL
    Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
    Soini T; Hurskainen R; Grénman S; Mäenpää J; Paavonen J; Pukkala E
    Acta Oncol; 2016 Nov; 55(11):1281-1284. PubMed ID: 27148621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed tumor: mucinous papillary cystadenocarcinoma associated with arrhenoblastoma.
    Curea M; Terzea D; Budu C; Ionescu V; Micu D
    Rom J Morphol Embryol; 1995; 41(3-4):129-31. PubMed ID: 8772369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma.
    Bossuyt V; Medeiros F; Drapkin R; Folkins AK; Crum CP; Nucci MR
    Int J Gynecol Pathol; 2008 Jul; 27(3):390-7. PubMed ID: 18580316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of low-grade intestinal-type mucinous neoplasm of the fallopian tube with KRAS exon 2 mutation.
    Nagahama K; Isomura A; Hayashi A; Momomura M; Kobayashi Y; Shibahara J
    Gynecol Oncol Rep; 2023 Oct; 49():101252. PubMed ID: 37583589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
    Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
    Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
    Morency E; Leitao MM; Soslow RA
    Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
    Morrison JC; Blanco LZ; Vang R; Ronnett BM
    Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant mucinous ovarian tumor with low malignant potential with foci of well-differentiated mucinous adenocarcinoma masked by massive obesity. A case report.
    Poole SY; Malone JM; Jacques SM; James A
    J Reprod Med; 1994 Dec; 39(12):982-4. PubMed ID: 7884758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology of the Fallopian Tube: Tubal Involvement by Ovarian Tumors and Incidental Findings in the Nontumoral Setting.
    Karpathiou G; Chauleur C; Venet M; Clemenson A; Peoc'h M
    Pathobiology; 2020; 87(1):37-44. PubMed ID: 31972564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications.
    Shan W; Mercado-Uribe I; Zhang J; Rosen D; Zhang S; Wei J; Liu J
    Cell Cycle; 2012 Jun; 11(11):2107-13. PubMed ID: 22592533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
    Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
    Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
    Baker PM; Oliva E; Young RH; Talerman A; Scully RE
    Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.